Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 102 | Longs Won 56/102 54% | Profit Factor 2.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7,767.51 |
| Average Win $5,361.8 | Best Trade (Feb 22) $41,482.65 | Sharpe Ratio -49.64 |
| Average Loss -$3,177.91 | Worst Trade (Feb 01) -$23,210.62 | Z-Score -2.61 (100%) |
| Commissions $0 | Avg. Trade Length 2m 5d | Expectancy $1,559.23 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.12% | 0.89% | 5.22% | 24.81% |
| Consecutive Losing Trades | 82 | 74 | 65 | 57 | 49 | 41 | 33 | 25 | 16 | 8 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 1,088.32 | $245,643.79 | $259,040.95 | - | $13,397.16 | 5.45% | +2.229% |